Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

JAK-STAT signaling in human disease: From genetic syndromes to clinical inhibition
Yiming Luo, Madison Alexander, Massimo Gadina, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 148, Iss. 4, pp. 911-925
Open Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

The interaction between ferroptosis and inflammatory signaling pathways
Yue Chen, Zemin Fang, Xin Yi, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 224
Structure of a Janus kinase cytokine receptor complex reveals the basis for dimeric activation
Caleb R. Glassman, Naotaka Tsutsumi, Robert A. Saxton, et al.
Science (2022) Vol. 376, Iss. 6589, pp. 163-169
Open Access | Times Cited: 120
Neuroimmune communication regulating pruritus in atopic dermatitis
Martin Steinhoff, Fareed Ahmad, Atul Kumar Pandey, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 149, Iss. 6, pp. 1875-1898
Open Access | Times Cited: 89
JAK inhibitors for rheumatoid arthritis
Satoshi Kubo, Shingo Nakayamada, Yoshiya Tanaka
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 4, pp. 333-344
Closed Access | Times Cited: 43
The JAK-STAT pathway: from structural biology to cytokine engineering
You Lv, Jianxun Qi, Jeffrey J. Babon, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 19
STAT6 gain-of-function variant exacerbates multiple allergic symptoms
Ichiro Takeuchi, Kumiko Yanagi, Shuji Takada, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 151, Iss. 5, pp. 1402-1409.e6
Open Access | Times Cited: 44
Severe allergic dysregulation due to a gain of function mutation in the transcription factor STAT6
Safa Barış, Mehdi Benamar, Qian Chen, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 152, Iss. 1, pp. 182-194.e7
Closed Access | Times Cited: 41
From thymus to tissues and tumors: A review of T-cell biology
Laura B. Chopp, Christopher Redmond, John J. O’Shea, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 151, Iss. 1, pp. 81-97
Open Access | Times Cited: 40
Pharmacokinetics and Pharmacodynamics of Ruxolitinib: A Review
Theo Y. Jerôme Appeldoorn, Thijs H. Oude Munnink, Linde M. Morsink, et al.
Clinical Pharmacokinetics (2023) Vol. 62, Iss. 4, pp. 559-571
Open Access | Times Cited: 29
Exploring the JAK/STAT Signaling Pathway in Hepatocellular Carcinoma: Unraveling Signaling Complexity and Therapeutic Implications
Hyun-Jung Park, S.-H. Lee, Jaehun Lee, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13764-13764
Open Access | Times Cited: 28
JAK/STAT signaling in diabetic kidney disease
Yingjun Liu, Wenkuan Wang, Jintao Zhang, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 27
Ferroptosis: an important player in the inflammatory response in diabetic nephropathy
Jialing Li, Luxin Li, Zhen Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 24
AKT Blocks SIK1-Mediated Repression of STAT3 to Promote Breast Tumorigenesis
Zicheng Sun, Qiwei Jiang, Bing Gao, et al.
Cancer Research (2023) Vol. 83, Iss. 8, pp. 1264-1279
Open Access | Times Cited: 23
JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study
Marco Fischer, Peter Olbrich, Jérôme Hadjadj, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 153, Iss. 1, pp. 275-286.e18
Closed Access | Times Cited: 23
Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX
Jérôme Hadjadj, Yann Nguyen, Dalila Mouloudj, et al.
Annals of the Rheumatic Diseases (2024) Vol. 83, Iss. 10, pp. 1358-1367
Closed Access | Times Cited: 16
Small molecule drug discovery targeting the JAK-STAT pathway
You Lv, Pengbing Mi, Jeffrey J. Babon, et al.
Pharmacological Research (2024) Vol. 204, pp. 107217-107217
Open Access | Times Cited: 13
Role of oxidative stress in mitochondrial dysfunction and their implications in intervertebral disc degeneration: Mechanisms and therapeutic strategies
Hao Zhou, Chenyu Wu, Yuxin Jin, et al.
Journal of Orthopaedic Translation (2024) Vol. 49, pp. 181-206
Closed Access | Times Cited: 11
Therapeutic potential of anticancer activity of nitrogen-containing heterocyclic scaffolds as Janus kinase (JAK) inhibitor: Biological activity, selectivity, and structure–activity relationship
Rohit Pal, Gurubasavaraja Swamy Purawarga Matada, Ghanshyam Teli, et al.
Bioorganic Chemistry (2024) Vol. 152, pp. 107696-107696
Closed Access | Times Cited: 10
Neuroinflammation in retinitis pigmentosa: Therapies targeting the innate immune system
Z. Zhao, Chen Hou, Naihong Yan
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 38
Malignant T cells induce skin barrier defects through cytokine-mediated JAK/STAT signaling in cutaneous T-cell lymphoma
Maria Gluud, Emil M. H. Pallesen, Terkild B. Buus, et al.
Blood (2022) Vol. 141, Iss. 2, pp. 180-193
Open Access | Times Cited: 32
SOCS-JAK-STAT inhibitors and SOCS mimetics as treatment options for autoimmune uveitis, psoriasis, lupus, and autoimmune encephalitis
Rahul Pandey, Marina Bakay, Hákon Hákonarson
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Insight into Janus kinases specificity: From molecular architecture to cancer therapeutics
Tian‐Hua Wei, Meng‐Yi Lu, Sihui Yao, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 7
Janus Kinase 3 (JAK3): A Critical Conserved Node in Immunity Disrupted in Immune Cell Cancer and Immunodeficiency
Clifford Liongue, Tarindhi Ratnayake, Faiza Basheer, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2977-2977
Open Access | Times Cited: 6
Baricitinib protects ICIs-related myocarditis by targeting JAK1/STAT3 to regulate Macrophage polarization
Xuejun Wang, Jiahui Chen, Yihui Shen, et al.
Cytokine (2024) Vol. 179, pp. 156620-156620
Closed Access | Times Cited: 5
JAK inhibition as a new treatment strategy for patients with COVID-19
Jin Huang, Chi Zhou, Deng Jinniu, et al.
Biochemical Pharmacology (2022) Vol. 202, pp. 115162-115162
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top